Chemi-Pharm AS of Harju Maakond at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Premium Exhibitor Manufacturers

Chemi-Pharm AS

Tänassilma tee 11, Tänassilma Küla, Saku, 76406 Harju Maakond
Estonia
Telephone +372 6 778806, +372 5 260612
chemi-pharm@chemi-pharm.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Enterprise Estonia EAS

Media files

Hall map

MEDICA 2021 hall map (Hall 15): stand G32

Fairground map

MEDICA 2021 fairground map: Hall 15

Contact

Ivari Koppel

Head of Sales and Export Department

Phone
+3725260612

Email
ivari@chemi-pharm.com

Edgar Viikmaa

Export Sales Manager

Phone
+37258070855

Email
edgar@chemi-pharm.com

Konstantin Rebrov

Business Development Manager

Phone
+3725175586

Email
konstantin@chemi-pharm.com

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.10  Hygiene / sterilisation / disinfection
  • 01.10.10  Hand hygiene systems and equipment
  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.10  Hygiene / sterilisation / disinfection
  • 01.10.11  Other equipment for hygiene / sterilisation / disinfection
  • 02  Laboratory equipment
  • 02.04  Cleaning equipment for laboratory
  • 05  Disposables and consumables
  • 05.05  Surface disinfectants
  • 05  Disposables and consumables
  • 05.06  Hand hygiene stations / supplies
  • 05  Disposables and consumables
  • 05.14  Personal protective equipment
  • 05.14.10  Other equipment for personal protection
  • 05  Disposables and consumables
  • 05.17  Other commodities and consumer goods

Our products

Product category: Other equipment for personal protection, Other commodities and consumer goods

BioBlock -- Nasal spray with antibodies against SARS-CoV-2

BioBlock® is a natural product derived from bovine colostrum that has been produced by cows, who had been hyperimmunized with the SARS-CoV-2 viral spike protein.
Bovine colostrum is a milk produced by cows within the first few days after giving birth. It contains antibodies that provide passive immunity to the newborn calf.

Product and its use
BioBlock® nasal spray is a natural product that contains antibodies against SARS-CoV-2 along with naturally occurring beneficial antibodies in colostrum which humans benefit daily while consuming dairy and meat products. In vitro testings demonstrated that the product blocks the entry of viral particles into cells. Tests were performed against initial Wuhan and newly mutated SARS-CoV-2 variants (alfa, beta, gamma, delta, kappa).
BioBlock® can be used wherever it is difficult to distance from others: at home, at work, at school, in gyms, in public transportation and in crowded places. This natural product does not cause dryness of nasal mucous membrane.

BioBlock® is not a medicine.

More Less

Product category: Surface disinfectants, Other equipment for hygiene / sterilisation / disinfection, Cleaning equipment for laboratory

Chemi-Pharm Surface Disinfectants

Chemi-Pharm offers  rapid surface disinfectants for medical devices and other surfaces where short contact time and high efficacy is required. Our broad range of solutions include products for disinfecting invasive and non-invasive medical devices, alcohol sensitive and water tolerant surfaces as well as products that combine both cleaning and disinfection. Our surface disinfection solutions are available as liquids, foams, concentrates and wipes.

More Less

Product category: Cleaning equipment for laboratory, Other equipment for hygiene / sterilisation / disinfection

Chemi-Pharm Instrument Disinfectants

Chemi-Pharm offers products for manual disinfection and pre-cleaning of all thermostable and thermolabile medical instruments. Our products cover a broad spectrum of microbiological efficiency, have excellent material compatibility, good cleaning properties and are convenient to use. Combining both cleaning and disinfection, our products are perfect for manual pre-treatment of medical devices, surfaces and instruments.

More Less

Product category: Hand hygiene systems and equipment, Hand hygiene stations / supplies, Other equipment for personal protection

Chemi-Pharm Hand Disinfectants

Chemi-Pharm offers rapid ethanol-based hand disinfectants for hygienic and surgical hand disinfection. Our products have been developed for professional use and are suitable for any situations with high hygiene requirements. Our hand disinfectants do not contain colourants, fragrances and will not leave your hands sticky after use.  In product development special attention has been paid to preventing user skin damage, dryness and irritation. Our product selection includes hand disinfectants  in both liquid and gel consistency, virucidal disinfectants as well as antimicrobial wash lotions.

More Less

Product category: Hand hygiene systems and equipment, Hand hygiene stations / supplies, Other equipment for personal protection

Chemi-Pharm Skin Antiseptics

Chemi-Pharm offers ethanol based rapid skin antiseptics  for use before surgical procedures, injections and punctures. Our products are gentle to the skin and with a broad spectrum of microbiological efficiency. We offer products with different remanence as well as colourless and colourant products to visualise the treated skin area. In product development special attention has been paid to preventing user skin damage and irritation.

More Less

Product category: Other equipment for hygiene / sterilisation / disinfection, Hand hygiene stations / supplies, Other commodities and consumer goods

Chemi-Pharm Skin Cleansing

Chemi-Pharm offers dermatologically tested skin cleansing lotions that are skin-friendly and soap-free. Our product selection includes wash lotions for everyday use in medical institutions as well as cream and foam for maintaining skin hygiene of immobile patients. Our products have been specifically developed for sensitive skin which is why  we use mild and safe ingredients and avoid fragrances and colourants.

More Less

Product category: Hand hygiene systems and equipment, Other equipment for hygiene / sterilisation / disinfection, Hand hygiene stations / supplies, Other commodities and consumer goods

Chemi-Pharm Skincare

Chemi-Pharm has developed a special hand cream series, avoiding skin damages and preserving normal micro flora of hands. Our product range includes water repellent skin protective cream as well as creams and lotions for sensitive and dry skin.  Our  products are especially suitable in medical institutions, where frequent hand washing is required.

More Less

Our trade marks

BioBlock

Company news

Date

Topic

01 Oct 2021

SARS-COV-2 ANTIBODIES IN BIOBLOCK NASAL SPRAY PROVEN TO SUPPRESS DELTA VARIANT

Laboratory testing of BioBlock nasal spray, which contains coronavirus antibodies, has demonstrated the product’s effectiveness in also blocking the delta variant currently spreading in Estonia. Tests have proven that BioBlock offers protection not only against the original Wuhan variant of the virus, but also against the delta and kappa variants of Indian origin and the British, South African and Brazilian variants.

“So far our laboratory tests have shown that BioBlock works effectively against all of the coronavirus variants the World Health Organisation is most concerned by, including the delta variant that’s currently spreading in Estonia,” explained Mart Ustav Jnr, the head of research at Icosagen. “We’re keeping a close eye on changes in the virus and doing preventive testing of BioBlock’s ability to neutralise variants that aren’t yet widespread.”

Dr Ruth Oltjer, the director of Chemi-Pharm, says that BioBlock is a textbook example of research-based product development. “Albeit born from a need to get the better of a global pandemic,” she remarked. “With the infection rate on the rise again, the best way of protecting yourself is by doing four things: vaccinating, wearing a mask, disinfecting your hands and using BioBlock.”

Approval for the production and sale of BioBlock came from the Health Board, taking into account the views of an expert working group on borderline products comprising specialists from the Agency of Medicines, the Agriculture and Food Board, the Consumer Protection and Technical Regulatory Authority and the Health Board itself. In legal terms, BioBlock is neither a medicinal product nor a medical device, but its product and packaging information was coordinated with both the Agency of Medicines and the Health Board.

The concept for this innovative Estonian product was developed by researchers from Icosagen, led by Professor Mart Ustav. The consortium established for the development and marketing of BioBlock consists of researchers and specialists from Chemi-Pharm, Icosagen, the University of Tartu, the Estonian University of Life Sciences and OÜ Teadus ja Tegu. The technology behind the product has been patented. BioBlock nasal spray is manufactured and marketed by Chemi-Pharm.

More Less

28 Sep 2021

TECHNOLOGY FOR THE MANUFACTURE OF SARS-COV-2 BIOBLOCK NASAL AND THROAT SPRAY BASED ON ANTIBODIES AGAINST SARS-COV-2 CORONA VIRUS WAS DEVELOPED AND PATENTED IN COOPERATION BETWEEN COMPANIES AND UNIVERSITIES

CONSORTIUM IN THE COMPOSITION: ICOSAGENI GRUPP, AS CHEMI-PHARM, OÜ TEADUS JA TEGU, ESTONIAN UNIVERSITY OF LIFE SCIENCES AND THE UNIVERSITY OF TARTU DEVELOPED AND PATENTED TECHNOLOGY FOR THE MANUFACTURE OF NASAL AND THROAT SPRAY SARS-COV-2 BIOBLOCK BASED ON ANTIBODIES AGAINST CORONAVIRUS SARS-COV-2.

In cooperation with Estonian companies and universities, a technology was developed that can be used to prepare a nasal and throat spray based on antibodies against SARS-CoV-2, which during initial research has shown its effectiveness in preventing coronavirus infection.

According to Professor Mart Ustav, who led the development of the new technology, their work is based on a preparation made from colostrum from hyperimmunized cows. “Colostrum has the best natural role in providing the newborn with primary protective immunity through antibodies produced by the mother’s body. For our part, we have developed a technology for purifying colostrum antibodies, which results in a preparation that can be used to make a nasal and throat spray, which in turn has the effect of preventing coronavirus infection,” Professor Ustav explained the positive effects of a novel product in the fight against coronavirus. Professor Ustav emphasized that it was not a drug but an antiviral preparation that works on the surface of the mucous membranes in the nasopharynx, where it can specifically inactivate the Covid-19 virus SARS CoV-2.

According to Prof. Ustav, preclinical tests have shown that the product produced had SARS CoV-2 virus-neutralizing activity. “We emphasize that these antibodies were effective not only against the virus strain that originated in Wuhan but also against new, more prevalent virus variants of Great Britain, South Africa, and Brazil, which we studied in biochemical as well as pseudovirus infection experiments. Animal experiments had shown that by instilling a solution of colostrum-derived antibodies in the nose one hour before infection with high levels of SARS-CoV-2, our preparation was able to significantly reduce the viral titer in the lungs. This indicates that the developed nasal and throat spray preparation is able to trap and neutralize the SARS-CoV-2 virus in the nasopharynx,” specified Prof. Ustav.

According to Ruth Oltjer, one of the leaders of the endeavor, the head of AS Chemi-Pharm, it is important to move quickly further from research. “The next step is for the consortium to conduct clinical trials and start producing SARS-CoV-2 BioBlock nasal and throat sprays containing the preparation as soon as possible,” Oltjer added. To this end, we have launched the production of SARS-CoV-2 BioBlock test batches and have submitted the protocols of the two clinical trials to the Research Ethics Committee of the University of Tartu for approval. These studies confirm the results of preclinical trials and provide a basis for the use of antiviral nasal spray as a prophylactic tool in the control of an extensive corona pandemic.

Ruth Oltjer added that the SARS-CoV-2 BioBlock could be helpful wherever social distancing is difficult: at homes, in restaurants, at schools, in sports practices, at sports competitions, at workplaces, in vehicles, and other crowded places. “It would be especially advisable to use the product on people that are in close contact with infected people, in order to reduce the risk of infection, as well as on infected people, so that these people would be less infectious to their loved ones,” Oltjer said, emphasizing that the SARS-CoV-2 BioBlock nasal and throat spray is not a substitute for vaccination or wearing a mask, but an additional measure to break the infection chains of the virus.

The consortium that developed the new technology includes Icosagen Grupp, AS Chemi-Pharm, University of Tartu (Institute of Pharmacy, Institute of Biomedical and Transitional Medicine and Institute of Technology), Estonian University of Life Sciences (Institute of Veterinary Medicine and OÜ Eerika farm), and OÜ Teadus ja Tegu.

Responsible composition of the consortium: Mart Ustav (Icosagen Group, mart.ustav@icosagen.com), Ruth Oltjer (AS ChemiPharm, ruth@chemi-pharm.com), Väino Poikalainen (OÜ Teadus ja Tegu, vaino.poikalainen@gmail.com), Toomas Tiirats (EULS, toomas.tiirats@emu.ee), Mario Plaas (UT, mario.plaas@ut.ee), Karin Kogermann (UT, karin.kogermann@ut.ee), Eva Zušinaite (UT, eva.zushinaite@ut.ee)

More Less

28 Sep 2021

AS CHEMI-PHARM AND INNOPOLIS INSENERID OÜ ENTERED INTO AN AGREEMENT FOR THE DESIGN OF A PHARMACEUTICAL FACTORY

An extension with cleanrooms will be added to the factory completed in Tänassilma Technology Park two years ago by Chemi-Pharm, a manufacturer of disinfectants and luxury cosmetics. Chemi-Pharm’s goal in expanding its production, warehouse, and commercial premises is in the near future to enter the pharmaceutical industry.
The extension of the production building has three floors and, together with the existing building, forms a whole. The extension of production, commercial and warehouse premises cover 8500m². The new production building will also include production areas with a higher cleanliness level, i.e., cleanrooms, which will be used in biotechnology, medicine, and other areas sensitive to air pollution. The air enters the cleanroom through a filter that traps all the air pollution. The air in the room is constantly re-filtered to remove contaminants from the room.

The COVID-19 pandemic has led to an increased worldwide need for both disinfectants and medicines. After the outbreak of the corona crisis, Chemi-Pharm became the most important supplier of disinfectants and care products for hospitals, nursing homes, and many other health care institutions in Estonia.

“We have been able to operate in the current factory building, which was completed only in 2019, for barely two years, and unexpectedly even to us, the building has occurred to be too small for us due to high demand,” says Kristo Timberg, CEO of Chemi-Pharm. “However, we are pleased that we had the opportunity to contribute and support hospitals, frontline staff, and society as a whole with disinfectants when they were most needed. But now we have to look further into the future again and increase our production capacity.”

Kristo Timberg added that in the near future Chemi-Pharm in cooperation with Icosagen Group, OÜ Teadus ja Tegu, and Estonian University of Life Sciences, and the University of Tartu, will also launch a new nasal spray, “SARS-Cov-2 BioBlock,” based on anti-SARS-CoV-2 antibodies. This provides additional protection against the coronavirus. “In the coming years, we plan to enter the field of pharmacy, for which we will establish a production unit based on cleanroom technology. The current crisis has shown that every country could have its own vaccine production capacity,” he added.

Tarmo Kastemäe, CEO of Innopolis Insenerid OÜ, states: “Innopolis Insenerid OÜ is one of the largest design bureaus in Estonia with in-depth experience in the field of healthcare and pharmacy. Our cooperation with Chemi-Pharm combines the best knowledge of two strong Estonian companies in the field of medicine and pharmacy. This creates an opportunity for the development of the Estonian pharmaceutical industry in the midst of a pandemic. We are pleased to contribute to Chemi-Pharm’s ambition to start manufacturing pharmaceuticals in Estonia and to increase the security of the Estonian people in the fight against the pandemic through the local pharmaceutical industry.”

Chemi-Pharm

Founded in 1997, Public Limited Company Chemi-Pharm develops, manufactures, and markets disinfectants, personal care products, cleaning and special care products, and the D’DIFFERENCE series of luxury cosmetics. Chemi-Pharm has subsidiaries in Malaysia and Singapore, but production is concentrated in Estonia, and the company’s head office is also located here.

Chemi-Pharm’s product list includes over a hundred different disinfection, cleaning, and care products, which in turn are divided into six main product groups: detergents, hand and skin antiseptics, skincare products, products for washing and disinfecting surfaces, products for washing and disinfecting instruments and cosmetics products. Today, the company exports its products to 27 countries, and in addition to medical institutions, customers also include the food industry, cleaning companies, children’s institutions, and schools.

Innopolis Insenerid

Innopolis Insenerid OÜ is a design bureau founded in 2007, which focuses on full-service building design solutions in Estonia and the Nordic countries. During its more than a dozen years of operation, the company has grown into one of the largest design bureaus in Estonia and a good partner in the construction of energy-efficient and sustainable buildings. Innopolis Insenerid OÜ has designed more than 140,000 m2 of healthcare and pharmaceutical buildings in the last ten years, which makes us one of the leading companies in the design of such buildings in the Nordic and Baltic countries.

More Less

28 Sep 2021

CHEMI-PHARM IS ONE OF THE NOMINEES IN ESTONIA FOR “INNOVATOR OF THE YEAR 2021”

We are honored to be one of the nominees in the Enterprise Estonia Enterprise Award 2021 competition in the “Innovator of the Year” category. The purpose of this category is to recognize companies that have achieved economic success through the development of innovations.

The best of the best will be revealed at the award event “Estonia’s Best Companies 2021” on the evening of October 7, which can be viewed on ETV on the same evening.

Read more: https://www.eas.ee/ettevotluseauhind/en/CHEMI-PHARM IS ONE OF THE NOMINEES IN “INNOVATOR OF THE YEAR 2021”

More Less

About us

Company portrait

Chemi-Pharm AS develops, manufactures and distributes allergen-free disinfectants, cleaning agents, maintenance products and natural skin care products for professional use in the medical sector. 

In Chemi-Pharm, user friendliness and environmental safety are the key principles. We care about purity, environment and health of each and every person who uses our products.

For over 20 years we have operated in the field of hygiene and infection prevention. All Chemi-Pharm products meet the high standards of the very demanding medical sector and the company's operating and manufacturing processes are in compliance with ISO 9001, ISO 14001 and ISO 13485.

Today Chemi-Pharm is the leading manufacturer in the Baltic States region and is represented in more than 25 countries around the world. Exports currently make up for more than 70% of the whole production volume and continue to grow.

Company data

Foundation 1997
Area of business Disposables and consumables

Company information as a PDF file